Madrigal Pharmaceuticals
MDGL
MDGL
138 hedge funds and large institutions have $780M invested in Madrigal Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 42 increasing their positions, 40 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
1.48% less ownership
Funds ownership: 71.69% → 70.21% (-1.5%)
35% less capital invested
Capital invested by funds: $1.2B → $780M (-$418M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
138
Holding in Top 10
3
Calls
$20.5M
Puts
$11.2M
Top Buyers
| 1 | +$13.1M | |
| 2 | +$8.52M | |
| 3 | +$7.87M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$6.39M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$5.88M |
Top Sellers
| 1 | -$62.8M | |
| 2 | -$7.59M | |
| 3 | -$7.34M | |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$5.18M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$3.36M |